• Profile
Close

Possible predictors for relapse from etanercept discontinuation in ankylosing spondylitis patients in remission: A three years’ following-up study

Clinical Rheumatology Aug 11, 2017

Zhao M, et al. – An observational study was conducted to evaluate the recurrence probability and the possible predictors in patients with ankylosing spondylitis (AS) from etanercept discontinuation. In AS patients who achieved the ASAS 20 response after receiving the treatment, no association was observed between the time of relapse and the duration of the treatment with etanercept. In addition, the older age and younger onset age of patients appeared to be important factors associated with an increased risk of relapse.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay